Aetna Inc. (AET) Shares Sold by Fulton Bank N.A.
Fulton Bank N.A. decreased its position in Aetna Inc. (NYSE:AET) by 14.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,756 shares of the company’s stock after selling 3,601 shares during the period. Fulton Bank N.A.’s holdings in Aetna were worth $3,151,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the company. FTB Advisors Inc. raised its position in shares of Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares during the last quarter. Signature Estate & Investment Advisors LLC acquired a new position in shares of Aetna during the first quarter valued at about $133,000. Horan Capital Management acquired a new position in shares of Aetna during the first quarter valued at about $157,000. Guardian Life Insurance Co. of America raised its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares during the last quarter. Finally, Tompkins Financial Corp purchased a new stake in shares of Aetna during the first quarter valued at $187,000. 91.69% of the stock is currently owned by institutional investors and hedge funds.
Aetna Inc. (AET) traded down 0.87% on Friday, reaching $154.45. 1,781,161 shares of the company were exchanged. The stock has a market capitalization of $51.29 billion, a price-to-earnings ratio of 34.28 and a beta of 0.54. The stock has a 50-day moving average price of $154.81 and a 200 day moving average price of $140.38. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $161.69.
Aetna (NYSE:AET) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.34 by $1.08. The firm had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. Aetna’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.21 EPS. Analysts forecast that Aetna Inc. will post $9.55 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Aetna Inc. (AET) Shares Sold by Fulton Bank N.A.” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/19/fulton-bank-n-a-sells-3601-shares-of-aetna-inc-aet-updated-updated-updated.html.
Several equities research analysts have weighed in on AET shares. Citigroup Inc. started coverage on shares of Aetna in a research note on Wednesday, June 28th. They issued a “buy” rating and a $180.00 target price for the company. Cleveland Research upgraded shares of Aetna from a “neutral” rating to a “buy” rating in a research note on Thursday, May 11th. Cantor Fitzgerald restated a “buy” rating and issued a $150.00 target price on shares of Aetna in a research note on Friday, May 12th. Barclays PLC restated an “overweight” rating and issued a $162.00 target price on shares of Aetna in a research note on Monday, May 15th. Finally, Credit Suisse Group restated a “buy” rating and issued a $155.00 target price on shares of Aetna in a research note on Wednesday, May 17th. Seven analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Aetna presently has a consensus rating of “Buy” and an average target price of $157.99.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.90% of the stock is owned by corporate insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.